ApconiX at the Ion Channel Conference!

Dr Mike Morton recently attended the Ion Channel Modulation Symposium at Clare College, Cambridge. The symposium brings together 200 scientists from academia, industry, CROs and academic drug discovery with lectures on diverse topics such as the role of ion channels in metastatic cancer, pain, and epilepsy. The symposium is organised by Sophion, makers of the QPatch instrument, used by ApconiX to deliver our CIPA ion channel assays.

By |2018-06-22T13:03:01+00:00June 17th, 2016|Events|Comments Off on ApconiX at the Ion Channel Conference!

About the Author:

Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath Director and Cofounder, ApconiX, UK and Chair and Director of Drug Discovery, University of Birmingham, UK Ruth is chair of drug discovery at Birmingham University, UK and Cofounder of ApconiX, an integrated toxicology and ion channel company that brings together a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development experience. Previously, Ruth was Global Head of Regulatory Safety at AstraZeneca and Director of Toxicology for Aventis. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development. With >140 publications in peer reviewed journals, she is focused on reducing attrition attributable to safety and toxicity. A former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and president elect of the Academy of Toxicological Sciences, Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology.